Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps

Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 5, 2004, Pages 585-589

  Woodworth, Bradford A ^a   Joseph, Kusumam ^b   Kaplan, Allen P ^b   Schlosser, Rodney J ^a,c  

^a Dept Otolaryngol Hd Neck Surg ^*  (United States)

^b Med Univ S Carolina 135 C   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 4; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NOSE POLYP; TH2 CELL; TISSUE LEVEL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; CHEMOKINES, CC; ENDOSCOPY; FEMALE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-5; MALE; MONOCYTE CHEMOATTRACTANT PROTEINS; NASAL POLYPS; PREDNISONE; RHINITIS; SINUSITIS; TH2 CELLS; TREATMENT OUTCOME;

EID: 7444244010     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2004.05.028     Document Type: Article

References (15)

1. P.J. Barnes Cytokine modulators as novel therapies for asthma Annu Rev Pharmacol Toxicol 42 2002 81 98
2. R.K. Kumar, C. Herbert, M. Yang Role of interleukin-13 in eosinophil accumulation and airway remodeling in a mouse model of chronic asthma Clin Exp Allergy 32 7 2002 1104 1111
3. S.R. Durham, S. Ying, V.A. Varney Cytokine mRNA expression for IL-3, IL-4, IL-5, and GM-CSF in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia J Immunol 148 1992 2390 2394
4. J.C. Gutiettez-Ramos Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung Immunol Rev 177 2000 31 42
5. P.D. Ponath Cloning of the human eosinophil chemoattractant, eotaxin expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils J Clin Invest 97 1996 604 612
6. S. Ying Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3 and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics J Immunol 163 1999 2160 2167
7. B.F. Marple Allergic fungal rhinosinusitis: Current theories and management strategies Laryngoscope 111 2001 1006 1019
8. M.S. Schubert, D.W. Goetz Evaluation and treatment of allergic fungal sinusitis II. Treatment and follow-up J Allergy Clin Immunol 102 3 1998 395 402
9. S.B. Kupferberg, J.P. Bent, F.A. Kuhn Prognosis for allergic fungal sinusitis Otolaryngol Head Neck Surg 117 1997 35 41
10. Anon JB, editor. Report of the Rhinosinusitis Task Force Committee Meeting. Otolaryngol Head Neck Surg 1997;117(3)Part 2+.
11. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
12. F.L. Jahnsen, R. Haye, E. Gran Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia J Immunol 163 3 1999 1545 1551
13. S.H. Shin, J.Y. Park, C.H. Jeon Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils Laryngoscope 110 8 2000 1353 1357
14. M.F. Kramer, P. Ostertag, E. Pfrogner Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis Laryngoscope 110 2000 1056 1062
15. L.M. Teran CCL chemokines and asthma Immunol Today 21 5 2000 235 242